LENS INSIGHT 09
HBM4 Testing Bottlenecks
Test Equipment, Yield and the Cost of Good Output
Key Conclusion
HBM4 testing creates economic value by reducing defect escapes and downstream losses while sustaining reliable good output—not simply by increasing test counts. Wider I/O and more complex stacks do not translate proportionately into equipment units, supplier revenue or profit. Value capture by Korean suppliers must be demonstrated through effective throughput, stable contact and thermal control, customer acceptance, repeat orders and cash collection.
Research Summary
Wider HBM4 data interfaces and more complex stacks and packages require changes in test coverage and resource allocation. Technical necessity, customer equipment orders, supplier revenue and cash remain separate milestones. This report distinguishes known-good-die (KGD) screening, known-good-stack (KGS) screening and final package/system validation, then maps the roles of testers, handling equipment, interfaces and thermal control.
Illustrative models examine how residual defect risk compounds with stack height, how parallel sites can offset longer test routines, and when lower defect escapes justify additional screening after false rejects and total testing cost. These calculations are not manufacturer yields, equipment quotations or company forecasts.
The Korean cases separate Techwing’s consolidated preliminary earnings from HBM4-specific contribution; treat UniTest’s HBM4 WAFER TESTER contract as evidence of demand rather than completed acceptance or cash collection; and distinguish TSE’s historically disclosed interface business from current HBM4 qualification. TradeLens sees value in validated combinations that lower the customer’s cost of reliable good output, rather than isolated peak specifications. Whether that benefit becomes supplier profit depends on generation-specific qualification, repeat orders, support costs and cash conversion.
Key Points
- KGD, KGS and final test serve different purposes; the product’s maximum transfer rate cannot be applied to every test stage.
- Screening can detect defects earlier and avoid downstream losses, but a test pass rate is not the same as manufacturing yield.
- Equipment demand depends on sites, availability, retesting, reuse and cell cost as well as test time.
- The net benefit of additional screening is avoided escape loss minus false-reject loss and incremental total test cost.
- Techwing, UniTest and TSE have different business scopes and evidence levels; qualification, acceptance, repeat orders and collection determine realized value.
Sources and corrections
The web summary introduces the report’s conclusions. Open the PDF to review the supporting material, calculations and assumptions. Figures and judgments refer to the analysis date shown above; publication does not mean that every figure updates automatically.
To report an error, include the report title, page number and supporting source through Contact. See the research reading guide (Korean) for more information.